Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy

This study has been terminated.
(Clinical hold)
Sponsor:
Information provided by (Responsible Party):
Akashi Therapeutics
ClinicalTrials.gov Identifier:
NCT01847573
First received: May 2, 2013
Last updated: April 21, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 21, 2017
  Primary Completion Date: April 21, 2017 (Final data collection date for primary outcome measure)